Substance / Medication

Carteolol hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Research and correlation analysis on the dripper contamination of carteolol hydrochloride eye drops.
Wang Ying-Ming, Ren Ya-Lu, Xu Jie et al. · Ann Palliat Med · 2021
PMID: 34154346Other
Efficacy of the combination of carteolol hydrochloride + latanoprost in the treatment of glaucoma and ocular hypertension.
Soares Rebecca Russ, Razeghinejad M Reza · Expert Opin Pharmacother · 2018
PMID: 30295543Other
Carteolol hydrochloride reduces visible light-induced retinal damage in vivo and BSO/glutamate-induced oxidative stress in vitro.
Matsuo Masato, Kuse Yoshiki, Takahashi Kei et al. · J Pharmacol Sci · 2019
PMID: 30580970Preclinical
Spectroscopic studies on the interaction of carteolol hydrochloride and urea-induced bovine serum albumin.
Yao Qing, Yu Xianyong, Zheng Tongyin et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2013
PMID: 23747387Preclinical
[Effects of carteolol hydrochloride on experimental choroidal neovascularization].
Ishida Susumu, Mochimaru Hiroshi, Nagai Norihiro et al. · Nippon Ganka Gakkai Zasshi · 2011
PMID: 21598603Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Carteolol hydrochloride (substance)
SNOMED CT
386867008
UMLS CUI
C0543450

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.